Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Should Sponsors Provide Source Document Templates?
Sponsor-provided templates provide a compelling opportunity to improve upstream trial execution. However, in today’s world of increasingly complex and data-driven trials, the opportunity comes with important caveats. read more
Engaging with Regulators for Single-Arm Oncology Research Trials
When well-planned and well-executed, single-arm trials can accelerate access to life-saving therapies that might otherwise never reach desperate cancer patients. read more
Executive Q&A - A Strategic Acquisition: Insights and Ideas
An interview with Brian Morrissey, General Manager of Gaelic Laboratories, which has acquired Athlone Laboratories in a strategic deal that typifies the current pharma M&A landscape and puts all of Ireland’s Beta-Lactam manufacturing capacity under one ownership umbrella. read more
Shore to Please
As this year is coming rapidly to a close, I thought it might be interesting to review the ten biggest announced projects since January: read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Scinai Finalizes Corporate Reorganization, Separates CDMO and R&D Operations
Thursday, April 09, 2026
Scinai Immunotherapeutics has completed a strategic corporate reorganization that establishes a dedicated contract development and manufacturing ... read more
Altruist Biologics' Hangzhou Facility Secures First Commercial Manufacturing License
Thursday, April 09, 2026
Altruist Biologics, an Innovent Biologics subsidiary and contract development and manufacturing organization (CDMO), announced that its Hangzhou ... read more
Ofichem Consolidates Brands Under Unified CDMO Identity
Thursday, April 09, 2026
Ofichem has unified its business divisions under a single brand identity, announcing that all operations will now trade under the Ofichem name. The ... read more
Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution
Tuesday, April 07, 2026
Azenta announced the appointment of Trey Martin as President of its Multiomics business, effective April 6, 2026. In this role, Mr. Martin will lead ... read more
Perceptive Discovery Expands In Vitro Capabilities at Needham, MA Site to Accelerate Preclinical Oncology Research
Friday, April 03, 2026
Perceptive Discovery announced a major expansion of its in vitro laboratory capabilities at its Needham, Massachusetts facility. This strategic ... read more